Sofinnova Investments, Inc. Akebia Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $1.63 Million - $8.92 Million	-681,892 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$6.67 - $13.58 $4.55 Million - $9.26 Million	681,892 New	681,892 $9.26 Million
Q4 2019 Feb 14, 2020	SELL	$3.16 - $6.73 $3.88 Million - $8.26 Million	-1,227,191 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.55 - $5.4 $1.34 Million - $2.05 Million	378,835 Added 44.66%	1,227,191 $4.81 Million
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $1.36 Million - $2.67 Million	331,595 Added 64.17%	848,356 $4.11 Million
Q1 2019 May 15, 2019	BUY	$5.41 - $8.73 $2.8 Million - $4.51 Million	516,761 New	516,761 $4.23 Million

120

54.9M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $417M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.